Bleximenib
Bleximenib (JNJ-75276617) oxalate is an orally active and highly selective menin–KMT2A interaction inhibitor, with IC50 values of 0.1 nM in humans, 0.045 nM in mice, and ≤0.066 nM in dogs, Bleximenib effectively suppresses tumor cell proliferation while inducing apoptosis and cellular differentiation. Bleximenib serves as a powerful investigational agent for leukemia and other KMT2A-driven malignancies in preclinical cancer research.
Product Specifications
CAS Number
2654081-35-1
Smiles
[C@@H] (CCCN (CCOC) C) (C (C) C) N1CC2 (CN (CC2) C=3C (OC4=C (C (N (C (C) C) CC) =O) C=C (F) C=C4) =NN=CN3) C1
Molecular Formula
C32H50FN7O3
Molecular Weight
599.8
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
124578-ML405 100 µL
CD209 (CD209 Antigen, C-type Lectin Domain Family 4 Member L, Dendritic Cell-specific ICAM-3-grabbing Non-integrin 1, DC-SIGN, DC-SIGN1, CLEC4L, MGC129965) (MaxLight 405) discontinued
Sign In for Pricing
View Details